The QualityStocks Daily Tuesday, August 28th, 2018

Today's Top 3 StockMarketWatch

MarketClub Analysis (AFMD) +246.88%

QualityStocks (INTV) +52.17%

NetworkNewsWire (MFMLF) +41.38%

The QualityStocks Daily Stock List

Lightwave Logic, Inc. (LWLG)

StockGuru, OTC Picks, Standout Stocks, FeedBlitz, PennyStocks24, SmallCap Fortunes, SmallCapVoice and HotOTC reported previously on Lightwave Logic, Inc. (LWLG), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Lightwave Logic is a technology business concentrating on the development of Next Generation Photonic Devices and Non Linear Optical Polymer Materials Systems for applications in high-speed fiber-optic data communications and telecommunications. The Company creates prototype electro-optic demonstration devices. Lightwave Logic is based in Longmont, Colorado. The Company lists on the OTC Markets Group’s OTCQB.

Lightwave Logic is moving toward commercialization of next generation photonic devices utilizing its high-activity and high-stability organic polymers for applications in data communications and telecommunications markets. The Company is using organic nonlinear electro-optical and all-optical polymers (plastic) as the foundation for a series of proprietary (internal and licensed to external partners) advanced Integrated Optical Devices that have wide-ranging applications in telecommunications, data communications, and optical computing for use in commercial and military markets.

Lightwave Logic has integrated its proprietary Perkinamine™ chromophore technology with other chromophores based in part on components of proprietary, in-licensed technologies. This has resulted in a strong and durable nonlinear organic electro-optical (EO) material, which will be used in photonic device development. It is founded on the Company’s multi-chromophore approach that enables two or more chromophores to work in concert.

The Polymer Photonics Integrated Circuit (P2ICTM) is similar to an electronic integrated circuit. However, it incorporates two or more optical functions or devices integrated onto a single substrate platform. Lightwave Logic’s expectation is that P2ICsTM will become a vital engine in the transceiver market over the next decade. The Company is developing its P2IC into prototypes.

Lightwave Logic announced earlier this year that it successfully demonstrated, together with its packaging partner, packaged polymer modulators designed for 50Gbps. The Lightwave Logic technical team worked together with its partner to complete the design with detailed attention paid to optical and electrical signaling issues.

In July, Lightwave Logic announced that Dr. Karen Liu joined the Company as Vice President of Sales and Marketing. Dr. Liu is a well-known industry analyst and marketing executive in Datacom and Telecom fiber optic communications. Her role at Lightwave Logic will be to advance the Company’s customer-facing position in the datacom and telecom markets via her technical, business, and investor expertise. Dr. Liu will help Lightwave Logic release 400Gbps and 800Gbps products based on the Company’s polymer PIC platform. 

Lightwave Logic, Inc. (LWLG), closed Tuesday's trading session at $1.04, down 1.89%, on 89,981 volume with 56 trades. The average volume for the last 60 days is 57,258 and the stock's 52-week low/high is $1.00/$1.64.

chart

Abattis Bioceuticals Corp. (ATTBF)

Greenbackers, Promotion Stock Secrets, InvestorIntel, CFN Media Group, Goldman Small Cap Research, Stockgoodies, Cannabis Financial Network News, PennyStocks24, and Information Solutions Group reported previously on Abattis Bioceuticals Corp. (ATTBF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Abattis Bioceuticals Corp. is a life sciences and biotechnology company based in Vancouver, British Columbia (BC). The Company has an operations office in Langley, BC. Abattis aggregates, integrates and invests in cannabis technologies and biotechnology services for the legal cannabis industry developing in Canada. The Company has successfully developed and licensed natural health products, medicines, extractions, and ingredients for the biologics, nutraceutical, bioceutical, and cosmetic markets. OTCQB-listed, Abattis Bioceuticals has positioned itself to be a leading service provider in the cannabis industry.

The Company’s brands include Northern Vine Labs™ and Vergence Naturals™. Abattis is also working to acquire exclusive intellectual property (IP) rights to agricultural technologies to be used in the extraction and processing of botanical ingredients and compounds.

Abattis has, through its operations and wholly-owned subsidiaries, a broad array of capabilities. These include cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal marijuana markets in North America.

The Company has a Federally Licensed Testing Lab. Its Northern Vine Labs holds a controlled substance dealers license from Health Canada. Northern Vine Labs' product formulation specialists can create and consult on custom developed products. Abattis Bioceuticals also has exclusive distribution rights to sell and service an industrial scale and cost-effective extraction technology.

Abattis Bioceuticals announced this past March that it completed its acquisition of a 90 percent ownership interest in Gabriola Green Farms, Inc. Gabriola is a BC company. Gabriola has applied for a license to produce (LP) under the Access to Cannabis for Medical Purposes Regulations (ACMPR) on Gabriola Island, one of the gulf islands located in the Strait of Georgia off the coast of BC. Gabriola currently has plans for an approximately 26,000 square-foot production facility to produce medical-grade marijuana located on 18 acres in the agricultural land reserve on Gabriola Island, BC.

In July, Abattis Bioceuticals announced that it entered into a definitive agreement with Emerald Health Therapeutics, Inc. to dispose of its 35 percent interest in Northern Vine Canada, Inc. in exchange for $2 million in cash and $4 million in freely tradeable common shares of Emerald Health Therapeutics.

In connection with this Agreement, Abattis Bioceuticals entered into a Master Services Agreement with Northern Vine to provide for Abattis’s continued use of Northern Vine’s laboratory as a “preferred customer”. This includes Abattis’s development work on a hemp-infused cannabinoid-rich, THC-free craft beer with Faculty Brewing Co. and also on nanoemulsified and liposomal platforms for transmucosal delivery of cannabinoid-rich hemp oil with the University of British Columbia.

Additionally, in July, Abattis Bioceuticals announced that it closed its investment in XLABS Therapeutics (ONT), Inc. Abattis and XLABS will be launching a new cannabis laboratory in Belleville, Ontario, to serve Ontario’s rising cannabis sector. The Laboratory (the Belleville Facility) will be housed in a 320,000 square foot building. Plans are for an initial build-out of 10,000 square feet and future expansion into the remaining 310,000 square feet via organic growth and more joint ventures (JVs).

This month it was reported that Emerald Health Therapeutics completed the purchase of the remaining shares of Northern Vine Canada, Inc. from Abattis Bioceuticals. The transaction increases Emerald’s ownership of Northern Vine from 65 percent to 100 percent.

Abattis Bioceuticals Corp. (ATTBF), closed Tuesday's trading session at $0.169, down 0.59%, on 2,583,313 volume with 472 trades. The average volume for the last 60 days is 1,471,816 and the stock's 52-week low/high is $0.0749/$0.7444.

chart

Mikros Systems Corp. (MKRS)

OTCEquity, PennyStocks24, AwesomeStocks, Wall Street Mover, PricelessPennyStocks, Promotion Stock Secrets, Marketbeat.com, Fast Money Alerts, Actual Gains, AddictivePennyStocks, Chatter Box Stocks, StockLockandLoad, PennyStockRumors.net, StockRockandRoll, StockBomb.com, ResearchOTC, and OTPicks reported on Mikros Systems Corp. (MKRS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Mikros Systems Corp. is a provider of advanced maintenance and monitoring solutions for mission-critical systems. The Company is an advanced technology enterprise that designs and manufactures specialized electronic systems for the Department of Defense. Its chief business is to pursue and obtain contracts from the Department of Homeland Security, the U.S. Navy, and other governmental authorities. The Company is headquartered in Princeton, New Jersey, and has its Manufacturing and Depot Center in Largo, Florida.

Mikros produces advanced maintenance systems for the Navy. These include the ADEPT Maintenance Automation Workstation and the ADSSS Condition Based Maintenance system for the Littoral Combat Ship. ADEPT systems are in use daily for performance optimization of advanced radar systems.

The Company has developed, delivered, and installed military-grade equipment to Federal customers’ for more than 30 years. Its capabilities include technology management, electronic systems engineering and integration, radar systems engineering, command, control, communications, computers and intelligence systems engineering, and communications engineering.

Mikros Systems’ Lifecycle Support capability is focused on ensuring the systematic interactions between Integrated Logistics Support (ILS), Depot, and Field Support activities are integrated to accomplish the highest levels of system readiness. The Company purchased certain software products, intellectual property (IP) and related assets from VSE Corp. The main software programs purchased by Mikros are the Prognostics Framework (PF) and Diagnostic Profiler (DP) programs.

The Diagnostic Profiler software is used globally by many multinational companies for optimized maintenance of varied product lines. Diagnostic Profiler is also used by the U.S. Air Force for depot test programs.

Prognostics Framework is used by the U.S. Army for many missile defense systems. These software products provide Mikros Systems with the opportunity to service commercial customers and additional Department of Defense customers outside the Navy.

In September 2017, Mikros Systems announced that it received the second production order awarded under its recent multi-year $35M contract with the Naval Surface Warfare Center in Crane, IN. This order covers new production deliveries of Mikros' Adaptive Diagnostic Electronic Portable Testset (ADEPT). It is valued at $2.4 million. The ADEPT units will be produced at the Mikros Manufacturing and Depot Center in Largo, FL.

Mikros has successfully completed the first ship and shore installation and testing of its ADEPT Distance Support Sensor Suite (ADSSS) on the Littoral Combat Ship USS INDEPENDENCE (LCS 2). As installed on LCS 2, ADSSS will utilize the Company’s proprietary model-based Prognostics Framework technology to monitor combat system elements to detect and predict on-ship system failures and apply predictive analytics to on-shore systems to detect broader maintenance trends and patterns across the fleet.

ADSSS Program Manager, Lori Ogles, said earlier in December, "Mikros has been a proud partner of the U.S. Navy for over fifteen years. We are honored to continue to support the readiness of U.S. Navy combat systems with our condition-based maintenance solution and we look forward to expanding the ADSSS technology to additional LCS and U.S. Naval platforms."

Mikros Systems Corp. (MKRS), closed Tuesday's trading session at $0.475, up 1.06%, on 9,193 volume with 13 trades. The average volume for the last 60 days is 19,229 and the stock's 52-week low/high is $0.30/$0.57.

chart

Kraken Robotics, Inc. (KRKNF)

OTC Markets, 4-Traders, Barchart, Morningstar, Stockhouse, InvestorsHangout, and TradingView reported on Kraken Robotics, Inc. (KRKNF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Kraken Robotics, Inc.’s commitment is to the production and sale of software, sensors, and robotic systems for the global Unmanned Maritime Vehicles market. The Company’s wholly-owned subsidiary is Kraken Robotic Systems, Inc. A marine technology company, Kraken Robotics is based in St. John’s, NL (Newfoundland and Labrador). The Company also has offices in Dartmouth, Nova Scotia; Bremen, Germany; and Fairfax, Virginia.

Kraken Robotics’ series of SAS (Synthetic Aperture Sonar) products named AquaPix® leverages almost 20 years of research and development (R&D) conducted by NATO’s Undersea Research Centre and millions of dollars in funding support from NATO government sponsors. AquaPix® provides comparable performance to existing high end military systems at a reduced cost.

AquaPix® can provide detailed seabed images with a constant resolution better than 3cm x 3cm out to a range of 300m from each side of an underwater vehicle (600m swath). Additionally, it can produce 3D bathymetric data with a resolution better than 25cm x 25cm out to full range. This is while delivering very high depth accuracy, in compliance with IHO S44 special order requirements.

Kraken Robotics has expanded from sensors to complete systems. The Company has introduced its KATFISH™ tethered underwater vehicle. Kraken has also introduced the THUNDERFISH® autonomous underwater vehicle (AUV). Furthermore, Kraken has its AQUATRAK® CVL product. This speed sensor is a derivative of its SAS technology. This product is for the oil and gas sector for ROVs.

Kraken also has its Kraken SeaVision™ system. This is an inventive new take on subsea 3D laser imaging. The design of it is to operate in a twin scanning configuration, with adjustable baseline. SeaVision can produce very high resolution 3D scans in full color.

In addition, Kraken has its DataPod™ product. The design of it is to meet contemporary data storage requirements for rugged marine applications. DataPod™ combines the user-friendliness of a Network Attached Storage system with the reliability of a RAID array and solid-state storage all in one compact unit.

Kraken Robotics’ wholly-owned subsidiary, Kraken Robotic Systems, Inc., is developing an ultra-wideband acoustic remote sensing system for seafloor imaging and mapping. The AquaPix® Multispectral Synthetic Aperture Sonar (SAS) will be the world’s first commercial SAS to operate over such a wide spectrum, ranging from low audible frequencies to high ultrasonic frequencies.

Last week, Kraken Robotics announced that Kraken Robotic Systems, Inc. signed a Cooperative Research and Development Agreement (CRADA) with the Office of Ocean Exploration and Research (OER) of the National Oceanic and Atmospheric Administration (NOAA). The data and information OER collect can be used to improve ocean research, inform policy and management decisions, develop new lines of scientific inquiry, and advise NOAA and the United States on vital issues.

Mr. Karl Kenny, Kraken Robotics’ President and Chief Executive Officer, said, “We feel this will be a truly symbiotic relationship between NOAA OER and Kraken by combining their real-time, global data transfer capabilities with our real-time processing incorporated to all of our sensors, allowing for high-resolution laser and sonar data to travel from the seafloor to researchers around the world at an unprecedented rate.”

Kraken Robotics, Inc. (KRKNF), closed Tuesday's trading session at $0.2642, down 3.26%, on 75,050 volume with 14 trades. The average volume for the last 60 days is 107,103 and the stock's 52-week low/high is $0.1064/$0.369.

chart

Bluestone Resources, Inc. (BBSRF)

MarketWatch, 4-Traders, OTC Markets, Barchart, Dividend Investor, Investors Hangout, OtcStockWatch.com, and Penny Stock Hub reported on Bluestone Resources, Inc. (BBSRF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

A mineral exploration and development company, Bluestone Resources, Inc. concentrates on advancing its 100 percent owned Cerro Blanco Gold and Mita Geothermal Projects in Guatemala. On February 14, 2018, the Company announced that its common shares began trading on the OTCQB Venture Marketplace. Bluestone Resources trades now on the OTCQB Venture under the symbol "BBSRF". Its common shares continue to trade on the TSX Venture Exchange under the symbol "BSR". Bluestone Resources has its corporate headquarters in Vancouver, British Columbia.

The Cerro Blanco Project economics and updated mineral resource estimate for Cerro Blanco indicates a strong project with an expected nine-year mine life producing 952,000 ounces of gold and 3,141,000 ounces of silver. Initial capital expenditures estimated in the Preliminary Economic Assessment (PEA) to fund construction and commissioning is estimated at US$170.8 million with all in sustaining cash estimated to be US$490 per ounce of gold produced. The Cerro Blanco Project is a classic hot springs-related, low sulphidation gold-silver deposit.

Last month, Bluestone Resources provided an update concerning the permitted Mita Geothermal Project situated adjacent to Bluestone’s Cerro Blanco Gold Project in Guatemala. The Mita Geothermal Project is in southeast Guatemala, roughly 160 kilometers by road from the capital, Guatemala City. The Company’s Board of Directors approved a flow test program to further test select geothermal wells with the aim of upgrading the confidence level of the known geothermal reservoir. The data collected will provide the foundation for the development strategy going forward.

A total of 19 geothermal wells have been drilled at the Mita Geothermal Project. This includes nine slim holes and ten standard diameter wells. US$60 million has been invested into this Project so far.

The Mita geothermal resource was discovered in the late 1990’s during gold exploration in southeastern Guatemala. Bluestone Resources controls the necessary surface rights for the Mita Geothermal Project and the Cerro Blanco Project. The Cerro Blanco Gold Project is not dependent on the Mita Geothermal Project. However, Company Management’s belief is that there are potential synergies between the two, which enhance the economics of the Cerro Blanco Gold Project beyond what was outlined in the PEA.

In addition, in January, Bluestone Resources announced an update on the exploration and in-fill drilling program now taking place at its Cerro Blanco Gold Project. The work is being undertaken in combination with the start of the Feasibility Study (FS) announced on September 18, 2017.

Recent results include numerous high-grade underground channel sample assays, for example 270.5 g/t Au and 637 g/t Ag over 2.5 m, which continue to confirm the bonanza-style veins and vein swarms at Cerro Blanco. Three drill rigs are presently operational on surface. Furthermore, an underground in-fill drill program has now started.

Last week, Bluestone Resources announced the creation of a Technical Advisory Committee (TAC). This is to provide impartial advice and peer review over the Cerro Blanco FS, expected to be completed by the end of this year. This Committee will help identify risks and opportunities working closely with Bluestone Resources’ Management and Consultants on material technical elements of the project.

A.L (Alf) Hills will Chair the Technical Advisory Committee. The composition of the committee will be made up of six members. These are Alf Hills, Allan Moss, Roger Nendick, Donald Scott, Robert Sim and Ward Wilson.

Bluestone Resources, Inc. (BBSRF), closed Tuesday's trading session at $1.0413, up 0.12%, on 10,000 volume with 8 trades. The average volume for the last 60 days is 1,992 and the stock's 52-week low/high is $0.8593/$1.35.

chart

DynaResource, Inc. (DYNR)

Vantage Wire, Stockwatch, Market Exclusive, Proactive Investors, Marketbeat, Marketwired, Dividend Investor, InvestorsHub, Wallet Investor, Market Screener, MarketWatch, Stockhouse, Real Investment Advice, The Street, Morningstar, 4-Traders, Barchart, OTC Markets, Investor Place, GuruFocus, Capital Cube, Simply Wall St and WSIC News reported on DynaResource, Inc. (DYNR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

DynaResource, Inc. is a Junior Resource Company listed on the OTCQB. It holds 80 percent of the outstanding shares of DynaResource de Mexico, S.A. de C.V., (DynaMexico). DynaMexico owns 100 percent of the mineral concessions and related interest to the San Jose de Gracia District (SJG). This covers approximately 69,133 hectares in Northern Sinaloa, Mexico. DynaResource has its head office in Irving, Texas.

At present, DynaUSA holds 80 percent of the total outstanding Capital of DynaMexico. DynaUSA presently holds 100 percent of DynaMineras.

The SJG is a 15 square kilometers mineralized area. It has historic production of 1 M Oz. Gold, bonanza grades. The Metallurgy Program is completed. It confirmed 95 percent recoveries in metallurgical testing and in pilot production operation. The SJG Property currently contains the potential for hosting a more than 3,000,000 Oz. AU resource.

DynaResource concentrated its efforts in mid 2006 on the financing, exploration, and development of SJG. At September 1, 2006, it signed a definitive agreement with Goldgroup Mining, Inc., to provide for an $18 million financing of exploration and development activities at the SJG. At March 15, 2011, Goldgroup had contributed the $18M.

DynaResource announced in 2017 that Mr. Eduardo Luna was appointed to the Company's Board of Directors, effective March 1, 2017. DynaUSA announced that its wholly-owned subsidiary, Mineras de DynaResource S.A. de C.V. (DynaMineras), the exclusive operator of the San Jose de Gràcia Project (SJG) in the State of Sinaloa, México, appointed Mr. Luna as Special Advisor to the President of DynaMineras.

For the SJG Project, a Surface Rights Agreement is completed. There is confirmation of major vein deposits; with bonanza grades. There is also location of bulk tonnage potential at Palos Chinos; (15 meters @ 3 grams/ton; 7m @ 7 grams/ton).

This past February, DynaResource, Inc. and DynaResource De Mexico SA De C.V. announced a favorable decision from a US District Court Magistrate Judge recommending the vacating of a 2016 arbitration award. DynaResource (DynaUSA) and its affiliate DynaResource de Mexico SA de C.V. (DynaMexico), the 100 percent owner of the San José de Gracia Project in Sinaloa, México (collectively DynaResource), announced that an earlier attempt by Goldgroup Resources, Inc. to confirm a global arbitration award adverse to DynaResource was rejected by a United States District Court.

In a detailed 31-page Recommendation, United States Magistrate Judge Kathleen M. Tafoya of the United States District Court for the District of Colorado determined the arbitration award must be vacated under the Federal Arbitration Act. The Recommendation was issued after Goldgroup moved to confirm the arbitration award; DynaResource filed a petition requesting the arbitration award to not be recognized and vacated. After the parties' dueling motions were filed, the Recommendation was issued.

DynaResource, Inc. (DYNR), closed Tuesday's trading session at $1.22, up 1.67%, on 1,100 volume with 3 trades. The average volume for the last 60 days is 564 and the stock's 52-week low/high is $1.00/$1.50.

chart

Nutra Pharma Corp. (NPHC)

Serious Traders, PennyStocks24, Streetwise Reports, MyBestStockAlerts, BUYINS.NET, UndiscoveredEquities, Wallstreetlivechat, Innovative Marketing, StocksToBuyNow, Pumps and Dumps and Winston Small Cap reported previously on Nutra Pharma Corp. (NPHC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Nutra Pharma Corp. is a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases. These include Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain. The Company is marketing Nyloxin® and Pet Pain-Away™ in the Over-the-Counter (OTC) pain management market. Listed on the OTC Markets, Nutra Pharma is headquartered in Coral Springs, Florida.

Via its subsidiaries, Nutra Pharma carries out basic drug discovery research and clinical development. The emphasis of the Company’s approach to drug discovery and the development of new therapeutic agents are based on specialized receptor-binding proteins found in nature, especially those found in snake venom from the cobra.

Nutra Pharma’s leading drug candidates are RPI-78M and RPI-MN. Its MS drug RPI-78M was previously granted Orphan Status by the Food and Drug Administration (FDA) for the treatment of Pediatric Multiple Sclerosis. The Company’s RPI-MN inhibits the entry of numerous viruses known to cause severe neurological damage in diseases such as encephalitis and AIDS. RPI-MN is undergoing development initially for the treatment of HIV. RPI-78M is undergoing development for the treatment of multiple sclerosis (MS).

The Company also looks for strategic licensing partnerships to lessen the risks associated with the drug development process. Its holding, ReceptoPharm, is developing technologies to produce drugs for HIV and MS. Nutra Pharma’s subsidiary, Designer Diagnostics, engages in the research and development (R&D) of diagnostic test kits designed to be used for the fast identification of infectious diseases. These include Tuberculosis (TB) and Mycobacterium avium-intracellulare (MAI).

Nutra Pharma offers a number of drug products for sale for pain treatment. One is Nyloxin®, the first OTC pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain. Nutra Pharma has launched Luxury Feet. This is a new version and packaging of its OTC pain drug Nyloxin. Another product is Nyloxin Extra Strength, the only non-narcotic and non-addictive treatment for severe (Stage 3) pain.

Nutra Pharma also has its Pet Pain-Away. This is the first OTC product to treat pain in companion animals without side effects. Pet Pain-Away is a homeopathic, non-narcotic, non-addictive, OTC pain reliever.

Last month, Nutra Pharma announced that it executed an agreement with American Marketing Technologies (AMT) to launch an integrated Internet marketing campaign united with a program to target several national retail chains. Recently, the Company re-launched its product websites. In addition, Nutra Pharma recently announced the infomercial campaigns specifically promoting Pet Pain-Away™.

Nutra Pharma Corp. (NPHC), closed Tuesday's trading session at $0.0007, even for the day, on 17,509,249 volume with 15 trades. The average volume for the last 60 days is 21,335,107 and the stock's 52-week low/high is $0.0004/$0.0069.

chart

Bion Environmental Technologies, Inc. (BNET)

TopPennyStockMovers, SECFilings.com News, OTC Stock Review, Wall Street Resources and Stock Guru reported earlier on Bion Environmental Technologies, Inc. (BNET), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Bion Environmental Technologies, Inc. is a developer of advanced livestock waste treatment and resource recovery technology. Its patented, next-generation technology provides verified comprehensive treatment of animal waste from large-scale livestock production facilities. Bion Environmental Technologies has its head office in Crestone, Colorado, and its administrative office in Old Bethpage, New York. The Company’s shares trade on the OTC Markets’ OTCQB.

Bion’s technology platform attains substantial reductions in environmental impacts. This includes nutrients (nitrogen and phosphorus), ammonia, greenhouse and other gases, and pathogens in the waste stream. This is while improving resource and operational efficiencies through the recovery of valuable byproducts.

Bion’s technology platform is a modular system. It can be configured in an assortment of ways, depending on farm- and region-specific needs. The system creates new revenue sources and opportunities for the producer.

Bion Environmental Technologies 2nd generation (2G) Comprehensive Environmental Management System removes up to 95 percent of the nutrients from the livestock waste effluent. It considerably lessens air emissions. This includes ammonia (as great as 90 percent or more), greenhouse gases, hydrogen sulfide, VOC’s, and others. The system extracts renewable energy from the waste stream in the form of cellulosic biomass.

The Company’s treatment solutions are a combination of biological, mechanical, as well as thermal processes. These are proven in commercial operations. They have been accepted by the EPA (Environmental Protection Agency), the USDA (United States Department of Agriculture), and other regulatory agencies.

Recently, Bion Environmental Technologies announced it received a Notice of Allowance from the US Patent and Trademark Office (USPTO) on its September 2015 patent application for an ammonia recovery process. This process converts the volatile ammonia in the livestock waste stream into stable concentrated ammonium bicarbonate. The Company’s process will enable the naturally-occurring ammonia and carbon dioxide in the livestock waste stream to be captured, separated, distilled, recombined and concentrated into a solid (crystal) ammonium bicarbonate.

Bion Environmental Technologies, Inc. (BNET), closed Tuesday's trading session at $0.774, down 2.64%, on 1,103 volume with 3 trades. The average volume for the last 60 days is 8,258 and the stock's 52-week low/high is $0.42/$0.96.

chart

Integrated Ventures, Inc. (INTV)

TradingView, MarketWatch, YCharts, OTC Markets, InvestorsHub, Barchart, and Investors Hangout reported on Integrated Ventures, Inc. (INTV), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, Integrated Ventures, Inc. concentrates on operating subsidiaries in the digital currency sector. The Company previously went by the name EMS Find, Inc. It changed its corporate name to Integrated Ventures, Inc. in July of 2017. Integrated Ventures is headquartered in Huntingdon Valley, Pennsylvania.

At present, the Company’s crypto portfolio includes BitcoLab – cryptocurrency mining and investing. It also includes Nemesis – manufacturing and sales of mining rigs and equipment.

Its portfolio also includes LoanFunder – the financial platform, designed to integrate with a decentralized and encrypted lending ledger. It offers a secure, efficient, verifiable, and permanent way of storing loan related information. Furthermore, Integrated Ventures’ crypto portfolio includes MMC – the manufacturing, marketing and operating of mobile mining centers.

In January 2018, Integrated Ventures announced that on January 25, 2018, it placed a Purchase Order with Bitmain Technologies for 140 mining rigs and related mining equipment. The expectation is that all newly purchased rigs will be deployed in the Company's new mining facility.

Last month, Integrated Ventures announced the signing of an Authorized Reseller Agreement with Shenzhen Halley Cloud Technology Company. Shenzhen Halley is the exclusive manufacturer of PandaMiners.

PandaMiner is a GPU integrated altcoin mining device. It supports manifold hashing algorithms, such as ETH and other cryptocurrencies. PandaMiner is assembled utilizing a high configuration graphics card, a customized and highly compatible case, and other optimized accessories for the highest mining efficiency.

With this Agreement, Integrated Ventures agreed to purchase 50 PandaMiner B3 Pro mining rigs with a total purchase value of $213,500. This cost includes 50 Power Source Units (valued at $6,250) and DHL shipping (valued at $3,750).

Moreover, in February, Integrated Ventures announced that it acquired CreditCalc from ITBS, LLC, a high-end loan management and calculation platform. The expectation is that this stock based transaction will speed up the development lifecycle of Integrated Ventures’ blockchain based lending platform - LoanFunder.

CreditCalc permits borrowers and lenders to perform complex calculations related to all kinds of loans. These include business loans, car loans, mortgages, as well as other financial instruments. Additionally, CreditCalc provides users an access to the custom credit programs and the ability to shop and compare for different kinds of loan products.

Recently, Integrated Ventures reported the filing with the SEC (Securities and Exchange Commission), of its Quarterly Report (Form 10-Q), for its Q2, ended December 31, 2017.

During the three months ended December 31, 2017, the Company reported Revenues totaling $105,088, comprising $59,498 in mining fees and $45,590 in mining equipment sales. The Cost of Revenues was $46,818. This resulted in a Gross Profit of $58,270 and Profit Margins of 55 percent.

Integrated Ventures, Inc. (INTV), closed Tuesday's trading session at $0.70, up 52.17%, on 74,402 volume with 53 trades. The average volume for the last 60 days is 34,656 and the stock's 52-week low/high is $0.0008/$6.74.

chart

Kiwa Bio-Tech Products Group Corporation (KWBT)

The Stock Psycho, Top Gun, Penny Stock Rumble, StockMister, The Penny Play, Equities.com, SmallCapVoice, Wallstreetlivechat, Lions of Wall Street, Fast Moving Stocks, Darth Trader, and OTC Picks reported earlier on Kiwa Bio-Tech Products Group Corporation (KWBT), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Kiwa Bio-Tech Products Group Corporation is a manufacturer concentrating on eco-friendly bio-based fertilizers promoting soil health. The Company develops, manufactures, distributes, and markets novel, cost-effective and environmentally safe bio-technological products for agricultural and environmental conservation. Kiwa Bio-Tech Products Group is based in Claremont, California.

The Company’s commitment is to eco-agricultural development and environmental control through developing, producing, and selling bio-technological products with high technology, low-cost, and high productivity to satisfy growing market demand. Kiwa Bio-Tech’s dedication is to making safe food, further developing eco-agriculture, and upholding a responsibility of contributing to China's agricultural safety, food safety, and a healthy lifestyle.

The design of the Company’s products is to enhance the quality of human life through increasing the value, quality, and productivity of crops and reducing the negative environmental impact of chemicals and other wastes. Kiwa Bio-Tech utilizes new bio-technological skills at its core. Organic, ecologically sound, and "green" practices are its theme.

Kiwa Bio-Tech has a strategic cooperation agreement with the Beijing Zhongpin Agricultural Science and Technology Development Center (Zhongpin Center). Zhongpin Center is the Chinese Agricultural Science and Technology Innovation and Development Committee's executive implementation agency (called the Agricultural Science and Technology Commission).

Through the guidance and support by the Zhongpin Center, Kiwa Bio-Tech will participate and be involved in China's National Soil Remediation Program and construction of the National Ecological Security Agriculture Industrial Chain Standardization System's operation and process.

Kiwa Bio-Tech has launched a joint venture (JV) with Zhongshi'an Agricultural Science & Technology Co., Ltd. and Xintaitianyi Financial Service and Science & Technology Co., Ltd. The name of the JV is Inner Mongolia Jingnong Investment Management Co. Ltd.

Kiwa Bio-Tech is a 40 percent partner in the venture. This venture will have an initial capitalization of roughly $1.5 million. Jingnong will invest in the expansion of Kiwa Bio-Tech’s existing production base in Shandong Province and in the construction of three new manufacturing bases of Kiwa in Inner Mongolia Province, Xinjiang Province, and Guizhou Province.

Recently, Kiwa Bio-Tech announced that it completed a repositioning and updating of its products. This is to meet the diverse market demands for biological organic fertilizers. The Company’s intention is that all of the new updated products will enter into the market next year.

The Company’s new products structure includes 16 types of products in 5 major categories. These categories are Biological Organic Fertilizer, Compound Microorganism Fertilizer, Microorganism Bacterium Agent, Biological Soluble Fertilizer, and Organic-Inorganic Compound Fertilizer.

Kiwa Bio-Tech Products Group Corporation (KWBT), closed Tuesday's trading session at $1.05, up 3.96%, on 2,100 volume with 3 trades. The average volume for the last 60 days is 3,369 and the stock's 52-week low/high is $0.89/$2.50.

chart

Seychelle Environmental Technologies, Inc. (SYEV)

PennyOmega, FeedBlitz, SmallCapVoice, PennyStocks24, and Stock Guru reported on Seychelle Environmental Technologies, Inc. (SYEV), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Seychelle Environmental Technologies, Inc., together with its subsidiaries, designs, assembles, and distributes water filtration systems around the world. The Company provides ionic adsorption micron filters chiefly for portable filter devices, which remove different pollutants and contaminants found in fresh water sources. Seychelle Environmental Technologies is based in San Juan Capistrano, California. Seychelle Water Filtration Products is a DBA of Seychelle Environmental Technologies.

Seychelle markets an extensive line of high-quality portable water filtration products and brands in North America and internationally. Its Ionic Adsorption Micron Filters are the most laboratory and field-tested of their type in the world using Environmental Protection Agency (EPA) protocols and tested to NSF/ANSI Standards 42 and 53 by Broward Testing Laboratory.

The Company’s products include flip-top and pull top bottles, canteens, water pitchers, pure water pumps, stainless steel bottles, in-line filters, pure water bags, pure water pouches, pure water straws, and radiological and PH filters, and also Pump 2 Pure. The Seychelle Pump 2 Pure Kit has Dual Supreme Filtration and one can filter their drinking water using Pump 2 Pure. It is built to reduce up to 99.9999 percent of cysts, bacteria, and viruses from almost any water source.

Seychelle Environmental Technologies offers its Seychelle Regular Filter, Seychelle Standard Filter, Seychelle Advanced Filter, Seychelle Radiological Filter, and Seychelle Extreme-Rad/Adv. Filter. Concerning the Seychelle Water Filtering Technology - Ionic Adsorption Micro Filtration, it is the only personal water filtration system capable of up to 99.99 percent reduction in all four areas of contamination. These four areas are Aesthetic, Microbiological, Chemical, and Dissolved Solids.

Seychelle Environmental Technologies, by way of its DBA Seychelle Water Filtration Products, has appointed the first exclusive sales agent for its New World Filter product in Sri Lanka. The Company said it would begin selling the new and highly profitable product elsewhere worldwide where quality drinking water is not available. The World Filter product requires the exclusive sales agent to source the bottle and cap locally. This is so the finished product will be priced competitively in the market.

In 2017, Seychelle has expanded its sales efforts in Mexico, Sri Lanka, Vietnam, South Korea, Australia, New Zealand, Japan, and China. The Company’s intention is to expand its marketing activities more strongly to the global market as well as E-commerce.

Seychelle is in the process of introducing a number of new products. These include a state-of-the-art drinking water straw for all water conditions and adding to its PH line of products, which includes a bottle and pitcher. Moreover, the Company is completing a hot/cool PH dispenser and await its UL approval.

Seychelle Environmental Technologies, Inc. (SYEV), closed Tuesday's trading session at $0.16, up 7.38%, on 106,519 volume with 9 trades. The average volume for the last 60 days is 26,561 and the stock's 52-week low/high is $0.10/$0.42.

chart

LD Holdings, Inc. (LDHL)

Tip.us, Innovative Marketing, Wall Street Reporter, pressreleasepoint, and Stock Guru reported earlier on LD Holdings, Inc. (LDHL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

LD Holdings, Inc. is a Financial and Management Holding Company headquartered in Perrysburg, Ohio. The Company’s emphasis is on acquiring businesses owned by Boomers who do not have an exit strategy. Its emphasis is on delivering venture capital level returns without the venture capital level risk. LD Holdings’ lists on the OTC Markets.

The Company concentrates on providing marketing, sales, and other business services that represent target services to position client companies for sales and profit growth in preparation for their eventual sale. LD Holdings also centers on maintaining a database of businesses for sale; maintaining a database of individuals with specific backgrounds and expertise for acquisition, evaluation, and strategizing the post-acquisition business model; and also maintaining a database of investors.

The Company works to source Boomer businesses, which fit LD Holdings’ acquisition criteria. LD Holdings will source and locate businesses with sales less than $25 million, profitable for the last 3 to 5 years, or have a well-defined path to profitability.

Additionally, LD Holdings will maintain a database of young entrepreneurial managers. It will maintain a database of talented individuals with different specific backgrounds. This will permit it to have expertise available for acquisition evaluation, and strategizing the post-acquisition business model for each potential acquisition, upon the financial facets of the transaction being determined.

LD Holdings will also look to acquire companies that have an existing management base, which can help in the transition to grow organically and profitably. It will also maintain and expand a database of investors to help finance acquisitions. The Company’s plan is to finance its objectives through the use of a qualified and screened database of up to 3,000 accredited investors (Angels and Institutions) and 1,500 non-credited investors.

This month, LD Holdings announced its update and guidance for its Baby Boomer acquisition strategy and capital plan needed to execute a round of five acquisitions. The Company has executed an agreement engaging a foremost New York Wall Street investment banking firm for their expertise and capabilities in sourcing and structuring the right acquisition capital that will permit LD Holdings to acquire profitable businesses in strategic industries, which will boost shareholder and investor value.

LD Holdings’ is focusing its immediate and near-term actions on executing a round of five acquisitions in the landscape architect, build and servicing space; implementing a transition and integration plan for newly acquired businesses; delivering revenue growth and operational efficiency targets; and positioning the public entity of LD Holdings for potential exchange up-listing and long term financial success.

LD Holdings, Inc. (LDHL), closed Tuesday's trading session at $0.065, up 29.22%, on 710 volume with 2 trades. The average volume for the last 60 days is 3,638 and the stock's 52-week low/high is $0.0503/$0.43.

chart

Asaleo Care Limited (ASLEF)

Penny Stock Tweets, The Street, Trade Ideas, Current Charts, Market Screener, TradingView, OTC Markets, Morningstar, Barchart, 4-Traders, Dividend Investor, Stockhouse, GuruFocus, MarketWatch, YCharts, Wallmine, Capital Cube and Wallet Investor reported on Asaleo Care Limited (ASLEF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Asaleo Care Limited is a foremost personal care and hygiene Company listed on the OTC Markets. It manufactures, markets, distributes and sells essential everyday consumer products. These products encompass the Feminine Care, Incontinence Care, Baby Care, Consumer Tissue and Professional Hygiene product categories.

Established in 1932, Asaleo Care has its corporate headquarters in Box Hill, Australia. The Company previously went by the name PEPSCA Limited. It changed its name to Asaleo Care Limited in May of 2014.

Asaleo Care is organized into three business units. These units are Consumer Tissue, Personal Care and Professional Hygiene. By way of its Consumer Tissue division, the Company manufactures and markets several top consumer brands. These include Sorbent toilet and facial tissue, Handee paper towel, Deeko disposable tableware, Purex toilet tissue as well as Treasures nappies (New Zealand only).

Via its Personal Care division, Asaleo Care manufactures and markets leading personal hygiene products under the Libra feminine hygiene brand and the TENA incontinence brand. The Company’s Professional Hygiene business delivers Tork hygiene solutions to the commercial, public, health care, food service and industrial segments.

Asaleo Care supplies dispensers, paper towels, toilet tissue, soaps, napkins and industrial and kitchen wipers under the international Tork brand. The majority of the Company’s brands hold number 1 or 2 market positions in Australia and New Zealand.

In addition, Asaleo Care has its Pacific Islands initiative. The Company is well represented in the Pacific Islands through the distribution of a broad set of Consumer Tissue, Tork Professional Hygiene and Personal Care products. It is also well represented through the presence of a manufacturing site near Suva in Fiji.

The Fijian plant produces toilet rolls, kitchen towels, serviettes, as well as facial tissues. The local brands Orchid and Viti are well known. These brands have market leadership in the Pacific Islands region.

Asaleo Care Limited (ASLEF), closed Tuesday's trading session at $0.585, down 0.85%, on 406,240 volume with 8 trades. The average volume for the last 60 days is 100,401 and the stock's 52-week low/high is $0.5151/$1.35.

chart

The QualityStocks Company Corner

The Flowr Corporation

The QualityStocks Daily Newsletter would like to spotlight The Flowr Corporation.

The Flowr Corporation, a Health Canada Licensed Producer (LP) of cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR), is an emerging Canadian cannabis leader founded by Medreleaf co-founder Tom Flow and a team of industry pioneers, successful start-up executives and top industry scientists. Flowr’s purpose-built cultivation facilities may be the most advanced in the industry, consistently generating high crop yields, delivering premium and ultra-premium cannabis products, and maximizing return on investment. The company also may be an R&D leader as it was selected by the Hawthorne Gardening Division of The Scotts Miracle-Gro Company as its exclusive Canadian cannabis R&D partner.

Flowr’s flagship facility, an 84,000-square-foot campus on seven acres in Kelowna, British Columbia, is engineered to grow premium cannabis in rooms that meet pharmaceutical industry production standards for cleanliness. This, along with exacting protocols designed by the Flowr team, enables Flowr to grow cannabis that meets Health Canada’s stringent standards without treating it with the taste- and smell-killing gamma irradiation that most other producers have to use to clean their product. Irradiating the plant – a process similar to pasteurizing food – impairs many of the important terpenes that provide the positive effects, flavors and scents of cannabis while strengthening unpleasant terpenes. Flowr’s products may deliver a better user experience, thus commanding premium prices.

Flowr’s cultivation facilities, built with proprietary, patent-pending systems, are designed to deliver yields targeted at 450 grams per square foot by the end of 2022, which is three times more efficient than the industry average of approximately 150 grams per square foot. By optimizing yield, the Company may produce significantly more cannabis flower on a smaller footprint than other producers, thus generating far high revenue per square foot and keeping costs much lower, leading to higher margins. The Kelowna facility is presently 20 percent operational with the remaining 80 percent slated to come online by early 2019. It is expected to produce up to 14,000 kg of premium, non-irradiated cannabis flower in 2019. With further enhanced yields and planned expansion of production facilities on the campus, Flowr will reach a total capacity of 60,000 kg annually in 2022.

Leading Flowr’s cultivation program is industry pioneer, company co-founder and Flowr president Tom Flow. Flow is widely recognized for his cannabis thought leadership and expertise building and operating cannabis cultivation facilities. Flow also co-founded MedReleaf and designed, built and set up SOPs for their flagship Marcum cultivation facility. Marcum has continued to be perhaps the most productive facility in the country prior to the Flowr flagship facility. Long one of Canada’s most efficient and profitable LPs, MedReleaf was acquired by Aurora for approximately C$3 billion. Flow and his team have designed and built a total of 17 cultivation facilities and secured three producer’s licenses under various Canadian regulatory regimes.

In March 2018, Flowr and the Hawthorne Gardening Division of The Scotts Miracle-Gro Company – a world leader in lawn and garden products – announced an exclusive strategic R&D alliance. After evaluating numerous Canadian LPs, Hawthorne chose to partner with Flowr based on the experience and expertise of the company’s cultivation and R&D teams and the company’s advanced growing capabilities.

Hawthorne will fund the construction of a 50,000-square-foot R&D facility that is integrated into Flowr’s Kelowna campus. This facility is North America’s first dedicated cannabis R&D facility focused on advancing cultivation techniques and systems. The facility will support researchers from both organizations and combine laboratories, indoor and greenhouse grow suites, training areas and genetics breeding areas in a single building. It is expected to open in early 2019. In addition to helping Flowr maintain its competitive advantage in cultivation, the company’s R&D program will keep it on the cutting edge of cannabis innovation.

Flowr is entering the market with three different brands to meet the growing demand for premium, non-irradiated cannabis in the medicinal and adult use markets:

  • FlowrRx, featuring premium quality medicinal cannabis that enables patients to live better, fuller lives. A dedicated Client Services team will provide patients with personalized support while an R&D team develops innovative flower strains and premium products targeted to specific conditions. Patient well-being is considered at every stage of the process – from genetic selection to harvest, trimming and curing techniques. FlowrRx and its team of passionate scientists and leading cultivation specialists are dedicated to advancing the scientific understanding of cannabis.
  • Flowr is the company’s premium recreational adult-use brand featuring an active, West Coast-inspired lifestyle for the cannabis connoisseur and enthusiast market. Through the continuous innovation of procedures and practices, Flowr’s talented team of experts is crafting premium products that deliver unparalleled experiences.
  • Ace Valley, an exclusive partnership with top-selling Ontario craft beer company Ace Hill, will bring Flowr’s premium product to the millennial and casual adult-use markets under the Ace Valley brand.

Flowr recently signed a Memorandum of Understanding with the British Columbia Liquor Distribution Branch, the province’s sole legal wholesaler of non-medical cannabis, to supply premium and ultra-premium flower to the province’s retail outlets. The company has agreements with several major medical distributors and is in discussions about retail distribution with additional provinces where it believes it can obtain prices commensurate with the quality of the Flowr products. The company is also evaluating other market opportunities including export.

Flowr is poised to become the pre-eminent indoor premium cannabis grower in Canada and one of the country’s top five LPs. The company’s focus on yield, quality and price point and its team’s ability to grow at scale should drive high margins, significant growth and strong return on investment.

Recent News

Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF)

The QualityStocks Daily Newsletter would like to spotlight Marifil Mines Ltd. (MFMLF).

The world’s appetite for battery-powered vehicles shows no sign of abating as major automakers announce plans to launch more than 400 models of electric vehicles (“EV”) by 2025, a report by Frost & Sullivan states (http://nnw.fm/O5dOc). Junior exploration company Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF) and its sizable portfolio of lithium and cobalt claims (another element used in key battery technologies) is positioned to benefit.

Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF), headquartered in Vancouver, Canada, is engaged in the exploration, evaluation and acquisition of mineral rich resource properties in Argentina. A rising global demand for cobalt and lithium is generating interest in Marifil Mines and its resources located within South America’s famed “Lithium Triangle,” which include 15,267 hectares spanning its recently acquired Ratones and Fraile claims, as well as two lithium properties covering the southern portions of the Carachi Pampa salar in the Argentine province of Catamarca.

The company’s property also includes the Las Aguilas nickel-copper-cobalt deposit property, with more than four contiguous claims in the San Luis province of Argentina. The Las Aguilas property, which is 100% owned by Marifil, is noted as one of the largest cobalt properties in Argentina. Other noteworthy properties in the company’s portfolio include the Toruel copper-silver property, with more than two contiguous claims, and additional potash properties in Punta Colorada, Pedernal and El Carmen.

Marifil’s sizable portfolio of cobalt and lithium claims in what is recognized as the world’s most prolific mining jurisdiction for these resources strategically positions the company to benefit as global initiatives push demand for lithium-ion batteries toward a frenzy. Zion Market Research, a leading research and consulting firm, has forecast that the lithium-ion battery market could hit $67 billion by 2022, realizing a CAGR of more than 13.7% from 2017-2022. Both lithium and cobalt are major components of these energy storage solutions, with industry data indicating that the battery industry currently consumes roughly 42 percent of global cobalt production.

The company is reviving a lithium exploration program that was active in Argentina a decade ago, building on an unexplored mine it owns there. Marifil will utilize a large proprietary geologic and geochemical data base it developed during its 2009 lithium exploration program in the Salta and Catamarca province sites to resume lithium exploration in the region.

Applications for a second mine and negotiations to purchase a third property are underway, which would establish a significant property portfolio of ‘salar’ brine evaporation lakes. Hydrothermal solutions emanating from regional faults in area volcanoes often enrich the brine with lithium, boron, potassium and magnesium.

In addition to nearly 152,000 acres of lithium-staked properties, Marifil owns 887 acres of land for cobalt exploration and 91,565 acres of gold mining rights in an advanced exploration stage in San Roque that company engineers indicate has high gold discovery potential with “excellent infrastructure and mining friendly politics.”

To date, more than $7.5 million has been invested assessing Marifil’s flagship San Roque gold property, including nearly 16,000 meters of diamond core drilling. The property is jointly owned by Marifil and Novagold Resources, with Marifil holding a 51% stake and serving as the current project operator. The company recently commenced a drilling campaign to further evaluate several deposits of significant gold-silver-indium-lead-zinc mineralization on a 4-kilometer-long zone.

Marifil has closed a private placement funding for $2 million that will inject additional life into the company. Proceeds from the funding will benefit acquisition plans, the ongoing drilling program at Marifil’s gold claim and other output from its general working capital accounts.

Robert Abenante, a chartered professional account, serves as president and chief executive officer of the company. He has extensive experience in the public markets and has served as an officer and director of several public and private companies across various industries, with particular success in the mining sector.

Marifil Mines Ltd. (MFMLF), closed the day's trading session at $0.1288, up 41.38%, on 58,488 volume with 22 trades. The average volume for the last 60 days is 14,628 and the stock's 52-week low/high is $0.01/$0.165.

Recent News

chart

CytoDyn Inc. (OTCQB: CYDY)

The QualityStocks Daily Newsletter would like to spotlight CytoDyn Inc. (CYDY).

CytoDyn Inc. (OTC.QB: CYDY), a biotechnology company developing a novel humanized CCR5 monoclonal antibody for multiple therapeutic indications, including treatment of HIV and cancer, announces the signing of a definitive agreement to acquire privately held ProstaGene, LLC. 

CytoDyn Inc. (OTCQB: CYDY) is a biotechnology company focused on the clinical development and potential commercialization of a new class of HIV/AIDS therapeutics or viral-entry inhibitors intended to protect healthy cells from viral infection. The company’s pipeline includes its lead product, PRO 140 for multiple indications among which are human immunodeficiency virus (HIV), graft-versus-host disease (GvHD), colon cancer, and multiple sclerosis (MS), each in various stages of development. CytoDyn first approval is focused on HIV indications for two different HIV populations.

PRO 140 is a humanized monoclonal antibody directed at CCR5, a molecular portal that HIV uses to enter T-cells. PRO 140 works by blocking the predominant HIV (R5) subtype entry into T-cells by masking this required co-receptor, CCR5.

CytoDyn has completed one pivotal phase 3 clinical trials of PRO 140 use in combination with current drugs for population that has limited treatment options. PRO 140 is also currently in another phase 3 (investigative trial) for a second approval for another HIV population. HIV continues to be a major global public health issue. There is no cure for the disease that has claimed more than 35 million lives to date, according to the World Health Organization (“WHO”). In 2017, 940,000 people around the world died from HIV-related causes. There were approximately 36.9 million people living with HIV at the end of 2017 with 1.8 million people becoming newly infected during that same year. The WHO estimates there were 21.7 million people globally receiving antiretroviral therapy (“ART”) in 2017.

HIV targets the immune system and weakens the body’s defense systems against infections and some types of cancer. As the virus destroys and impairs the function of immune cells, infected individuals gradually become immunodeficient which results in increased susceptibility to a wide range of infections, cancers and other diseases that people with healthy immune systems can fight off. The most advanced stage of HIV infection is Acquired Immunodeficiency Syndrome (AIDS), which can take from 2 to 15 years to develop depending on the individual.

PRO 140 functions by blocking the HIV co-receptor CCR5, a molecular portal HIV uses to enter T-cells, thus preventing the HIV virus from entering the cell. CCR5 is a protein located on the surface of white blood cells that normally serves as a receptor for chemicals that attract immune cells to the site of inflammation. Clinical trials to date indicate PRO 140 does not interfere with these normal CCR5 functions. Results from phase 1 and phase 2 human clinical trials have shown PRO 140 significantly reduces viral burden in people infected with HIV. Importantly, in a recent phase 2b clinical trial, PRO 140 demonstrated it can allow a subset of R5 strain of HIV population to replace their current HIV regimen (Highly Active Antiretroviral Therapy or “HAART.”) by a simple sub-cutaneous self-injectable dose of PRO 140 which is administered once a week. Some of those patients have received PRO 140 as their only therapy for almost four years.

The PRO 140 antibody appears to be a powerful antiviral agent with hardly any side effects, toxicity. More than 500 patients have used PRO 140 in clinical trial and no resistance has ever been developed in any patients including patients in monotherapy of PRO 140 for almost four years.

PRO 140, which is taken as an easy-to-use, weekly, subcutaneous self-administered dose, has almost no side effects or toxicity with no report of any serious adverse event related to PRO 140 in more than 500 patients in eight different clinical trial.

As we indicated earlier patients given PRO 140 showed no drug resistance on monotherapy for some almost four years while 76% of HAART patients developed a resistance to some portion of the lifetime drug regimen. Patient compliance with HAART is also the main reason why only 35% of HIV patients in US reporting complete viral load (VL) suppression which is VL<50 cp/mL.

In addition to its research into the powerful potential of PRO 140 for use in HIV patients, CytoDyn is pursuing PRO 140 as a therapeutic anti-viral agent in other non-HIV indications that could benefit from PRO 140’s ability to block CCR5. These immunologic indications include new reactions to cancer, transplantation rejection, autoimmune diseases and chronic inflammation such as Multiple Sclerosis. The company sees the significant potential for multiple pipeline opportunities for PRO 140.

The U.S. Food and Drug Administration has designated PRO 140 as a “fast track” product for HIV and granted Orphan Drug Designation to it for the prevention of GvHD in transplant patients. CytoDyn has initiated its first clinical trial with PRO 140 in an immunological indication for GvHD in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who are undergoing bone marrow stem cell transplantation. The company is also investigating PRO 140 in animal models of cancer progression and autoimmunity with positive results and has published its animal study results in GvHD in peer-reviewed journal.

CytoDyn president and CEO Nader Z. Pourhassan, Ph.D. joined the company in 2008 and is credited for purchasing PRO 140 from Progenics in 2012 and has taken a new path to approval for the product. He is the co-inventor of monotherapy path for PRO 140. He has taken PRO 140 development from phase 2 to Completed successful phase 3 in about four years. He now has more than 10 years of drug development experience and has overseen the rapid clinical development of PRO 140 as a therapy for HIV into two phase 3 for two different indications. He also initiated PRO 140 first immunological indication in GvHD (currently in phase 2). He is also involved in preclinical and clinical development of PRO 140 in additional immunological indications.?Dr. Pourhassan, who has more than 20 years of business development experience, has led CytoDyn’s capital market activities since joining the company in 2008. He received his Bachelor of Science from Utah State University, Master of Science from Brigham Young University, and his Ph.D. in Mechanical Engineering from the University of Utah and is the author of three books.

CytoDyn Inc. (CYDY), closed the day's trading session at $0.585, up 6.36%, on 190,104 volume with 60 trades. The average volume for the last 60 days is 332,059 and the stock's 52-week low/high is $0.40/$0.836.

Recent News

chart

Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Net Element, Inc. (NASDAQ: NETE) has reported strong second quarter financial results, with net revenues of $32.45 million by June 2018, up nine percent from $29.7 million last year (http://nnw.fm/79sUP). The financial services technology company, which develops multi-channel electronic payment solutions, has seen a significant increase in its North American business.

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

Net Element has also launched a new blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed the day's trading session at $6.25, up 5.22%, on 423,658 volume with 1,405 trades. The average volume for the last 60 days is 121,802 and the stock's 52-week low/high is $2.556/$33.51.

Recent News

chart

BLOCKStrain Technology Corp. (TSX-V: DNAX)

The QualityStocks Daily Newsletter would like to spotlight BLOCKStrain Technology Corp. (DNAX).

BLOCKStrain Technology Corp. (TSX.V: DNAX) provides the first integrated blockchain platform that registers and tracks intellectual property for the cannabis industry. This pioneering effort has not gone unnoticed in an industry that’s expected to explode in the next decade. One report indicates that by 2027, the legal cannabis industry in North America will grow from $9.2 billion last year to approximately $47.3 billion, with $57 billion being spent worldwide (http://nnw.fm/23Tf9).

BLOCKStrain Technology Corp. (TSX-V: DNAX), a full-service software company headquartered in Vancouver, BC, Canada, has developed the first integrated blockchain platform that registers and tracks cannabis intellectual property (“IP”) from genome to sale. It is proprietary, immutable and cryptographically secure, thereby establishing a single source of truth for cannabis strains and their ownership.

With Canada set to legalize marijuana use for recreational purposes, and other jurisdictions following suit around the world, new challenges will emerge regarding the ability to provide a safe and legal inventory of a product that up until now was largely only available on the black market. Cannabis will be heavily tested and regulated by numerous regulatory bodies in Canada. The cannabis industry faces unique challenges that BLOCKStrain specifically helps it address, including:

  • Mandatory Testing: Through BLOCKStrain’s platform and lab-testing partners, the process is more efficient and streamlined, cutting the administrative burden in half and getting products to market faster;
  • DNA Based Product Validation: The underlying blockchain technology creates a genetic fingerprint that identifies and validates the product electronically so any participant on the platform, including consumers, can view and track what’s happening with that product from genome to sale;
  • Intellectual Property: Third, and perhaps most importantly, the BLOCKStrain platform protects the intellectual property of growers and breeders. This is important for the industry’s growth as products evolve and develop. If a craft grower, for example, creates a popular strain with unique characteristics, it will be able to protect its intellectual property by simply registering the strain’s genome with BLOCKStrain and locking that data into the blockchain. It will reside there forever and will be readily accessible in the event of future disputes, bringing a level of trust to the industry and ensuring licensing fees are paid to all players in the market.

VERIFICATION = CERTIFICATION

BLOCKStrain’s genetics verification process is authentic and incredibly effective. User groups register by creating an account with BLOCKStrain, which starts the process. Organizations and independent growers submit seeds, flower and post-extraction product for testing to a registered and approved testing facility, which then submits test results to BLOCKStrain. Pre-existing data of genetic cannabis strains can also be submitted via BLOCKStrain verification administrators, with those results being added to the user group’s blockchain account. Submissions are entered into BLOCKStrain, and the transaction is completed and recorded.

Each time an item is tested and verified by the network, a Registration Affidavit is auto-generated and given a unique “BLOCKStrain Address” along with a traceable QR Code. Producers, patients and consumers are able to not only verify the test but can also rate the product, write reviews and share opinions. This detail is stored within BLOCKStrain and, just like the test results, cannot be tampered with or modified. Verification and certification are earned by all parties for their participation.

SAFE CONSUMER SUPPLY

BLOCKStrain demystifies the seed-to-sale process for all relevant stakeholders including producers, distributors, shippers, government agencies and consumers by creating a repository of cannabis genomes on an immutable, shared ledger. Thousands of cannabis strains exist and cultivators are breeding new strains all the time. The proliferation of cannabis strains can prove problematic for consumers since there are more than 500 known chemical compounds in a single plant. Furthermore, since several dozens of these compounds have been identified as pharmacologically active, it becomes more and more difficult for consumers to know what they are purchasing.

It is for this reason that being able to quantify the genetics, potency and equivalencies among cannabis products is crucial to the future of legalized cannabis. The difference is not so much in the name or brand attached to the cannabis, but the DNA of the plant itself. BLOCKStrain ensures product integrity, safety, regulatory compliance, product licensing and authenticity – all vital elements for the emerging cannabis industry.  This technology also bolsters the process of meeting government regulatory standards by providing real-time visibility of industry operations to agencies assigned to enforce and regulate cannabis activity.

INTELLECTUAL PROPERTY RIGHTS

BLOCKStrain allows for the defense of intellectual property rights for the grower with an authentic, verifiable chain of evidence embedded in the blockchain itself. Proof of ownership for a specific strain of cannabis is paramount in a multibillion dollar industry. Real life ownership disputes have already begun in the industry with legal battles underway. Unfortunately, the framework for resolving these disputes has yet to be defined and they are not likely to be resolved anytime soon.

Consumers and regulators alike want to know whether a cannabis product grown and sold at a local dispensary is safe and meets quality control standards. BLOCKStrain enhances trust of origin from genome-to-sale as cannabis flows through the supply chain, verifying critical steps in the process such as who is growing the plant, which seed is planted and where did it come from, whether pesticides were used, how much was grown, which tests are used to establish quality and potency, where the product is transported and how, and whether possession limits are meeting regulatory standards.

In summary, BLOCKStrain has developed the most comprehensive, secure and community-driven cannabis genetics archival platform for cannabis breeders and growers, large and small, to protect and release their varieties into the public domain, all while compensating and rewarding them for their contributions.

BLOCKStrain Technology Corp. (DNAX), closed the day's trading session at $0.24, up 4.35%, 397,860 volume. The stock's 52-week low/high is $0.105/$1.20.

Recent News

chart

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)

The QualityStocks Daily Newsletter would like to spotlight Foresight Autonomous Holdings Ltd. (FRSX).

Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX), an innovator in automotive vision systems, announced today the additional sale of a prototype of its breakthrough QuadSight™ quad-camera vision system. The QuadSight™ multi-camera vision solution targets the semi-autonomous and autonomous vehicle market and is designed to allow near-100 percent obstacle detection with near zero false alerts under any weather and lighting conditions.

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.

Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.

The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.

Foresight has developed three main products:

  • QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
  • Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
  • Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.

In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.

Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.

Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.

Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.

Foresight Autonomous Holdings Ltd. (FRSX), closed the day's trading session at $2.9444, up 1.53%, on 15,100 volume with 64 trades. The average volume for the last 60 days is 54,291 and the stock's 52-week low/high is $2.44/$8.20.

Recent News

chart

Pressure BioSciences Inc. (OTCQB: PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences (OTCQB: PBIO) was recently covered in a Zacks Research Report issued on July 26, 2018, which forecasted PBIO to grow at a compound annual growth rate (CAGR) of 76 percent in the next five fiscal years from 2018 to 2022 (http://nnw.fm/F3GhM). To view the full article, visit: http://nnw.fm/xN2e2.

Pressure BioSciences Inc. (OTCQB: PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed the day's trading session at $3.49, up 8.39%, on 2,031 volume with 10 trades. The average volume for the last 60 days is 1,654 and the stock's 52-week low/high is $0.70/$5.00.

Recent News

chart

SinglePoint, Inc. (OTCQB: SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint Inc. (OTC:SING) provides video update from Greg Lambrecht, CEO. Additionally, the company has provided an audio version of its previous press release. To watch the video update: https://youtu.be/vBu24OoK3ns. To listen to the previous press release: https://youtu.be/6NV4lApTTWg.

SinglePoint, Inc. (OTCQB: SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.0318, up 2.42%, on 5,112,923 volume with 200 trades. The average volume for the last 60 days is 6,183,016 and the stock's 52-week low/high is $0.0235/$0.133.

Recent News

chart

Auscrete Corp. (OTC: ASCK)

The QualityStocks Daily Newsletter would like to spotlight Auscrete Corp. (ASCK).

Auscrete Corp. (OTC: ASCK), operating out of Washington State, focuses on making affordable, technology driven and eco-friendly housing. The company constructs energy efficient housing and commercial structures built from Auscrete-developed lightweight hybrid concrete/insulation wall and roof panels.

Auscrete Corp. (OTC: ASCK) is a building products manufacturer of environmentally-friendly, energy-efficient housing and commercial structures using a lightweight hybrid concrete material developed through a proprietary technology. Auscrete’s unique process produces a medium that is cost-efficient, extremely soundproof, offers high insulation values, requires very low maintenance, won’t burn, non-toxic, highly resistant to insects and mold, and resists damage from hurricane forces and earth tremors. It’s a more affordable, energy-efficient “green” construction material that can be utilized for building residential housing and commercial structures.

Affordable homes are increasingly becoming more difficult to purchase in the U.S. with the median price of a new home consistently rising while wages stay stagnant in many areas and mortgage rates rise. The average price of new homes sold in the U.S. in 2017 was nearly $385,000, according to Statista. The homeownership rate in the U.S. has been in decline since 2004, the report states, and now amounts to a little more than 64 percent of Americans.

Auscrete’s lightweight concrete product is described as an aerated concrete material following infusion of a specially designed foaming agent during manufacture. This technology enables the product to have millions of minuscule air bubble “aggregates” introduced and evenly distributed throughout the cast sections, which creates a unique, lightweight product without compromising strength or structural integrity. Each hybrid panel also incorporates a distinctive XPS insulation amalgamation that guarantees greater comfort in a wide range of climatic conditions and a reduction in heating and cooling costs. The final product is a light and strong concrete panel with an extremely high insulation value, as well as excellent fire resistance and sound-proofing qualities.

Auscrete’s product also offers a high strength-to-weight ratio, allowing architects and engineers to develop new design and construction concepts that take advantage of the product’s reduced weight, which is nearly half that of normal concrete. Each panel can be cast in large sections, a common size being 16-feet by 8-feet, for easier transportation and faster construction on site. Savings are enhanced, not only by the energy efficiency of each panel, but through the use of mass production techniques. Auscrete estimates the company can produce a ready-to-move-in turnkey house for around $100 per square foot, which is significantly less than the 2017 median list price of $148 per square foot in the U.S., according to a report by Zillow.

Auscrete is constructing its flagship, 10-acre facility in Goldendale, Washington, on initially 5 acres the company recently purchased with the option to purchase another 5 adjacent acres. This new campus will ultimately comprise of 6 buildings, including 3 production buildings of 25,000 sq. ft. with each production buildings’ capacity of 100 homes annually, giving this flagship facility the ability to produce 300 homes or equivalent commercial structures per year.

During this construction phase, Auscrete has leased a commercial building in Goldendale. The facility will be used as a temporary headquarters and will also serve as a refurbishing station for production equipment the company has developed and used in its prior production plant. John Sprovieri, CEO and founder of Auscrete Corporation, is at the helm of the company with Mike Young serving as vice president of internal operations and Otto Paulette controlling the in-house mechanical services.

Auscrete’s Investor Relations Director, Lee Odom said, “The company’s construction process has already attracted interest from many developers, contractors and builders, some with large tracts of land looking to make available, significant numbers of Affordable Homes throughout the Country. Additionally, there have been significant commercial projects offered including 300 room destination hotel resorts, correctional facilities, a shopping complex, and a court house along with a flood of inquiries from people who are looking for more affordable building options”.

“This could really launch the commercial aspect for?ASCK, apart from residential home production which so many investors are not yet aware of,” Odom said. “A strong combination of both will lead?ASCK?to better performance through all business cycles, thus continuing to enhance the shareholder values, which is always the ultimate goal of Auscrete Corporation.”

Auscrete Corp. (ASCK), closed the day's trading session at $0.0551, even for the day, on 26 volume with 2 trades. The average volume for the last 60 days is 119,377,422 and the stock's 52-week low/high is $0.0001/$0.10.

Recent News

chart

Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF)

The QualityStocks Daily Newsletter would like to spotlight Phivida Holdings Inc. (PHVAF).

Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) is pleased to announce the appointment of Mr. Brian Schmitt as its new Creative Director responsible for new product packaging design and brand visual identity.  In his career, Mr. Schmitt worked to bring innovation and art to globally respected brands such as Nike, Apple and Google.

Headquartered in Vancouver, Canada, with operations offices in southern California, Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) is a premium food and beverage company that develops CBD-infused functional foods, beverages and supplements poised for global distribution. All products in the Phivida label are infused with organic, hemp-derived cannabinoids into a variety of premium foods, beverages and clinical products for everyday health. Phivida is guided by a team of Fortune 500-caliber executives focused on a new strategic portfolio of products and brands, comprehensive consumer research, new product and brand development, improved visual identity and packaging design, and a strong distribution strategy.

The company’s motto – “Celebrating Health and Wellness, in Harmony™” – underscores Phivida’s mission to lead the alternative health care sector as the benchmark standard in premium CBD-infused functional beverages and tinctures. To execute this goal, Phivida is taking advantage of positive legislative developments in the United States and has defined an elevated national route-to-market strategy across the U.S. where small regional distributors will be now be replaced with large national distributors.

Management

Phivida’s management team includes president and CEO Jim Bailey, former president of Red Bull Canada and global chief marketing officer for Merrell Outdoors; Chief Marketing Officer Michael Cornwell, former chief marketing officer for Samsung New Zealand and the former director of marketing for Red Bull Canada; and Doug Campbell, former director of sales for Red Bull North America, who as Phivida’s chief commercial officer is tasked with driving new sales revenue growth.

Publicly traded on the Canadian Securities Exchange (CSE.VIDA) and recently graduated to the OTCQX Best Market in the USA (OTCQX.PHVAF), the company’s strong balance sheet carries CAD$15.7 million with no debt or loans with less than 60 million shares outstanding and the company is now well-capitalized to fun major mainstream distribution with a solid structure poised for long-term growth.

The Science

Using encapsulation technology, Phivida uses full spectrum CBD-hemp oil (rich in naturally occurring phytocannabinoids) converted into a water-soluble delivery format, which enhances delivery and absorption of the cannabinoids into the human body – up to an estimated tenfold.

Encapsulated CBD is infused into functional beverages, food and supplements containing a proprietary blend of phytonutraceuticals studied to target a range of health and wellness conditions. Phivida tests every product for microbials, heavy metals, pesticides, residual solvents, terpenes, and potency to guarantee less than 0.3 percent THC (tetrahydrocannabinol, the chemical compound in cannabis responsible for a euphoric high) is present.

Regulations

Federally legal under the 2014 Farm Bill, CBD from Hemp Oil is a rapid growth market across the USA. When derived from marijuana, CBD remains a schedule one controlled substances, giving hemp derived CBD oil infused products a competitive advantage on regulations. On June 28, 2018, the U.S. Senate passed the Agriculture Improvement Act of 2018 (i.e. the “Farm Bill), lifting the USA Industrial Hemp laws to an agricultural commodity status and effectively removed hemp from the controlled substance list.

Earlier this year, another milestone court ruling also provided significant regulatory support for the US CBD-Hemp sector. In February 2018, the Supreme Court preceded over the HIA (Hemp Industry Association) vs. DEA (Drug Enforcement Agency) in a class-action suit concerning the issue of CBD extracted from hemp, and the legality of industrial hemp. In the final ruling the Supreme Court unequivocally determined that – when produced domestically under the Farm Bill – hemp (and its derivatives) are not a controlled substance.

The Supreme Court ruling also found the Farm Bill (as it relates to hemp) “pre-empts” the Controlled Substances Act. Congress has since exempted Farm Bill hemp from the Controlled Substances Act (CSA) giving the Farm Bill primary jurisdiction over the governance of the CBD-Hemp Oil industry in the USA.

The DEA further conceded it does not “seek to control cannabinoids,” and that only marijuana derived cannabinoids are governed under the Controlled Substances Act. In May of 2018, the DEA issued a formal directive to all federal agencies (e.g. US Customs and Border Patrol) stating that cannabinoids are not controlled substances unless derived from marijuana, and that the “mere presence of cannabinoids” in any product or derivative does not render it a controlled substance. The Supreme Court ruling also resulted in the mediation of a settlement in what is now the third successful HIA vs. DEA suit in over a decade.

In Canada, the Senate approval of Bill C-45 legalized the production, distribution and use of recreation cannabis – with edibles to be added in 2019. The bill will officially become law as of October 17, 2018, creating a legal framework for the production, distribution, sale and possession of cannabis across Canada including cannabinoid-infused beverages.

3 Wholly Owned Subsidiaries

  • Phivida Organics Inc. offers professional-grade, wholesale, whole plant hemp oil extracts made from 100-percent certified organic hemp stalk. Phivida’s hemp oil extracts are CO2-extracted under quality assurance/clinical standards and are third-party lab tested to assure only pharmaceutical grade, cGMP certified, full-spectrum products are produced and available for sale. Phivida Organics produces hemp oil extracts that deliver nano-encapsulated cannabinoids in water soluble formulations designed to be absorbed up to 10 times faster than other oils, providing up to 400 percent bioavailability. Phivida Hemp Oil Vida+ extract products are available now online at www.Phivida.com.
  • Phivida Nutrition blends the best of nature into CBD-infused lifestyle branded beverages including a variety of CBD infused iced teas and CBD infused flavored waters.
  • Phivida Enhanced – Under the VIDA brand, CBD-infused tinctures, capsules and other supplement products are distributed to alternative health care clinics across the USA.

WeedMD-Phivida

Phivida has signed a binding letter of intent to joint venture WeedMD Inc. (TSX-V: WMD) (OTC:WDDMF) (FSE:4WE), a Health Canada federally licensed producer and distributor of medical cannabis, to form a joint venture focused on cannabis-infused beverages. The new joint-venture company, Cannabis Beverages Inc. (“CanBev”), plans to develop a production facility at WeedMD’s state-of-the-art greenhouse facility in Strathroy, Ontario, Canada. CanBev is on track to build and operate the first cannabis-infused beverage production facilities in Canada. The joint venture will focus on manufacturing, marketing and distribution of cannabinoid-infused beverages for the legalized medical and adult-use cannabis markets.

Management from both WeedMD and Phivida are collaborating on design and engineering strategies and site evaluations on a 610,000-square-foot, state-of-the art facility in Strathroy for the development of CanBev. As an emerging certified food grade production plant, the Strathroy facility is an ideal location and comes is equipped with extensive production infrastructure, including 50,000 sq. ft. of food production and packaging area, cold storage, loading docks, and adequate space to expand for future growth.

Strategic Agreements

Phivida Organics has also entered into an agreement to carry out a pharmacokinetic (PK) study on its hemp-derived, nanoencapsulated CBD with Artelo Biosciences Inc. at the University of Nottingham, School of Medicine at the Royal Derby Hospital, England. The study will test encapsulated-CBD on healthy volunteers and measure how fast and how much CBD enters the blood stream after oral consumption with each of the different formulations developed by Phivida Organics.

Phivida has also activated distribution agreements with Asayake Inc. to become one of the first federally approved CBD-infused food and supplement brands in Japan. With first mover status achieved, Phivida now markets to an underserved, yet highly informed population of 127 million patients and practitioners. The supplement market in Japan is estimated at US$10 billion with the overall functional foods market at US$21 billion. The Asia-Pacific region is the fastest growing market for natural plant-based supplements. Phivida now plans to prepare a formal application to Japan’s Consumer Affairs Agency to register the company’s CBD-infused functional food and beverage products for approval under the country’s Food with Functional Claims regime. The functional beverage market in Japan is estimated at US$10.35 billion with a CAGR of 2.5 percent (2015-2025).

Further Information

www.Phivida.com
+1 (844) 744-6646 (ext. #2)
IR@Phivida.com

Phivida Holdings Inc. (PHVAF), closed the day's trading session at $0.6056, off by 3.37%, on 69,203 volume with 58 trades. The average volume for the last 60 days is 36,265 and the stock's 52-week low/high is $0.05/$1.80.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF), one of the most popular Canadian licensed producers, and its plans to become a leader in the cannabis beverage space with the establishment of its Beverage Science and Research Division.

The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $4.30, off by 3.52%, on 667,010 volume with 1,364 trades. The average volume for the last 60 days is 225,584 and the stock's 52-week low/high is $2.784/$7.565.

Recent News

chart

Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

Youngevity International, Inc. (NASDAQ: YGYI), a leading omni-direct lifestyle company, launched several highly anticipated new products at their 2018 Convention in San Diego, California, between Aug. 23 and 25.

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $4.10, off by 2.61%, on 13,943 volume with 55 trades. The average volume for the last 60 days is 16,437 and the stock's 52-week low/high is $3.1674/$6.75.

Recent News

chart

Sugarmade, Inc. (OTC: SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade, Inc. (OTC: SGMD), one of the largest publicly traded hydroponics supply companies, today announces the filing of a disclosure statement with the Securities & Exchange Commission concerning possible acquisitions by the Company. Sugarmade has begun formal acquisition negotiations with two companies that provide online and retail hydroponic and other agricultural cultivation supplies. Also today, SGMD was highlighted in an article describing how the worldwide market for cannabis is projected to hit $31.4 billion by 2021, according to a report from research firm Brightfield Group.

Sugarmade, Inc. (OTCQB: SGMD) one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.

Sugarmade, Inc. (SGMD), closed the day's trading session at $0.14, off by 12.45%, on 5,688,331 volume with 555 trades. The average volume for the last 60 days is 808,254 and the stock's 52-week low/high is $0.0219/$0.43.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.